These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 31402535

  • 21. Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society.
    Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S, Japanese Liver Transplantation Society.
    Am J Transplant; 2018 Mar; 18(3):659-668. PubMed ID: 28889651
    [Abstract] [Full Text] [Related]

  • 22. Long-term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta-analysis.
    Shingina A, Vutien P, Uleryk E, Shah PS, Renner E, Bhat M, Tinmouth J, Kim J.
    Liver Transpl; 2022 Mar; 28(3):437-453. PubMed ID: 34331391
    [Abstract] [Full Text] [Related]

  • 23. Current status of organ transplantation in Japan and worldwide.
    Yoshimura N, Okajima H, Ushigome H, Sakamoto S, Fujiki M, Okamoto M.
    Surg Today; 2010 Jun; 40(6):514-25. PubMed ID: 20496132
    [Abstract] [Full Text] [Related]

  • 24. Regulatory T-cell activation among patients who displayed operational tolerance following intra-portal administration of donor-specific antigens in living donor liver transplantation.
    Sato Y, Chikako T, Oya H, Yamamoto S, Kokai H, Miura K, Hatakeyama K.
    Transplant Proc; 2012 Mar; 44(2):560-4. PubMed ID: 22410069
    [Abstract] [Full Text] [Related]

  • 25. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors.
    Irie R, Nakazawa A, Sakamoto S, Takeda M, Yanagi Y, Shimizu S, Uchida H, Fukuda A, Kasahara M.
    Liver Transpl; 2020 Jul; 26(7):899-905. PubMed ID: 32314485
    [Abstract] [Full Text] [Related]

  • 26. Current Status of Living Donor Liver Transplantation in the United States.
    Abu-Gazala S, Olthoff KM.
    Annu Rev Med; 2019 Jan 27; 70():225-238. PubMed ID: 30355261
    [Abstract] [Full Text] [Related]

  • 27. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.
    Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA, A2ALL Study Group.
    Am J Transplant; 2009 Feb 27; 9(2):301-8. PubMed ID: 19120082
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group.
    Liver Transpl; 2007 Jan 27; 13(1):122-9. PubMed ID: 17192908
    [Abstract] [Full Text] [Related]

  • 30. Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match.
    Ohe H, Waki K, Yoshitomi M, Morimoto T, Nafady-Hego H, Satoda N, Li Y, Zhao X, Sakaguchi S, Uemoto S, Bishop GA, Koshiba T.
    Transpl Int; 2012 Jan 27; 25(1):97-106. PubMed ID: 22117557
    [Abstract] [Full Text] [Related]

  • 31. Section 16. Update on experience in paired-exchange donors in living donor liver transplantation for adult patients at ASAN Medical Center.
    Jung DH, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Park GC, Lee SG.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S66-9. PubMed ID: 24849838
    [Abstract] [Full Text] [Related]

  • 32. Impact of graft thickness reduction of left lateral segment on outcomes following pediatric living donor liver transplantation.
    Kitajima T, Sakamoto S, Sasaki K, Narumoto S, Kazemi K, Hirata Y, Fukuda A, Imai R, Miyazaki O, Irie R, Teramukai S, Uemoto S, Kasahara M.
    Am J Transplant; 2018 Sep 27; 18(9):2208-2219. PubMed ID: 29673096
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 27; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 27; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.
    Levitsky J, Kaneku H, Jie C, Walsh RC, Abecassis M, Tambur AR.
    Am J Transplant; 2016 Aug 27; 16(8):2437-44. PubMed ID: 26896194
    [Abstract] [Full Text] [Related]

  • 39. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, A2ALL Study Group.
    Am J Transplant; 2012 Nov 27; 12(11):2997-3007. PubMed ID: 22994906
    [Abstract] [Full Text] [Related]

  • 40. Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation.
    Zhang R, Zhu ZJ, Sun LY, Wei L, Qu W, Zeng ZG, Liu Y.
    Transplant Proc; 2018 Dec 27; 50(10):3601-3605. PubMed ID: 30577244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.